In TP53 wild-type AML cell lines, iron reversed the reduction in BCL2 expression and the increase in BAX expression triggered by cytarabine; however, similar effects were not observed in TP53 mutant-type cells (Figure 4H). This evidence concerns the gene BCL2 and acute myeloid leukemia.